|
|
| Maladies Infectieuses > Etude de marché sectorielle |
| Monoclonal Antibody Based Products |
|
|
|
|
€ 2 308,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Octobre 2005 |
Taille du document : |
489 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Stakeholder Insight: Psoriasis - Biologics Impact Treatment Regimes Across the Globe
203 pages | Février 2005 |
IntroductionPsoriasis is a non-life threatening but highly debilitating disease that currently has no cure.
Traditional treatments often either lack efficacy or are effective but have very poor sid |
12 160,00 €
|
| |
| |
Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution
237 pages | Avril 2005 |
IntroductionLess than 50% of chronically infected hepatitis C patients do not benefit from the current standard of care, pegylated interferon plus ribavirin.
In the short-term, the treatment landsc |
9 120,00 €
|
| |
| |
03-054: Immunohistochemistry Market Benchmarking Survey
90 pages | Octobre 2003 |
This report provides an overview of the most commonly used methods and products for tissue/sample preparation and antigen detection to help suppliers understand researchers’ experiences, preferences a |
680,00 €
|
| |
| |
Commercial Insight: Herpes and Respiratory Antivirals - Leaders Rise and Fall
218 pages | Octobre 2005 |
IntroductionWithin the herpes and respiratory antiviral subcategory HSV/VZV products have been key growth drivers, accounting for 77% of a market worth $2,190m in 2004.
Despite lost of US branded V |
9 690,00 €
|
| |
| |
Stakeholder Insight: Hepatitis B & C - Winning Battles But Not The War
329 pages | Décembre 2004 |
IntroductionAccording to the WHO, 350400 million are chronically infected with HBV and 170200 million with HCV.
Although HBV vaccination and routine screening of donated blood has decreased inciden |
12 160,00 €
|
| |
| |
Monoclonal Antibody Therapies: Evolving into a $30 billion market
360 pages | Avril 2005 |
IntroductionThe monoclonal antibody market is one of the fastest growing and most lucrative sectors of the pharmaceutical industry, with exceptional 48.1% growth between 2003 and 2004.
It has the p |
12 160,00 €
|
| |
| |
Cytology and HPV Testing World Markets
183 pages | Mars 2006 |
The purpose of this report is to describe the specific segment of the diagnostic market aimed at analysis cytology (the examination of cells using optical microscopy methods) specimens derived from th |
2 800,00 €
|
| |
| |
Chinese Markets for Vaccine
200 pages | Août 2003 |
China's demand for vaccine has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trends, |
2 835,00 €
|
| |
| |
Pipeline Insight: HIV - Hold Your Horses
216 pages | Avril 2005 |
IntroductionIn the current antiretroviral landscape, resistance in all three of the established classes is proving to be problematic.
Accordingly, current clinical trials are recruiting treatment-r |
9 120,00 €
|
| |
| |
Therapeutic Vaccines: More Trials and Tribulations
202 pages | Décembre 2005 |
IntroductionTherapeutic vaccines have faced numerous setbacks in recent years.
The only three vaccines to reach the market have had insignificant sales, while the pipeline has seen numerous high-pr |
6 460,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Monoclonal Antibody Based Products |
|
|
This report analyzes the worldwide markets for Monoclonal Antibody Based Products in Millions of US$. The major product segments analyzed are Therapeutics, and Diagnostics. The sub product segments analyzed include Cancer, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of world. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 84 companies including many key and niche players worldwide such as Abgenix, Amgen, BD Biosciences, Biogen Idec Inc., Biotest AG, Cambridge Antibody Technology , Celltech, Dendreon Corporation, Elan Corporations Plc, Eli Lilly, Genentech, Inc., Guildhay, Human Genome Sciences, ICOS, Immunomedics, Johnson & Johnson , Centocor, Medarex Inc, Medlmmune Inc, Protein Design Labs, Inc., Strategic BioSolutions, and Wyeth Pharmaceuticals.
|
|
Monoclonal Antibody Based Products
|
|
|
PPLSEN
|
|
|
|
|
